Choudhury Khushboo, Ghooi Ravindra
Post Graduate Student, Symbiosis School of Biomedical Sciences, Symbiosis International University, Lavale, Mulshi, Pune 412 115 INDIA.
Indian J Med Ethics. 2013 Jul-Sep;10(3):197-200. doi: 10.20529/IJME.2013.058.
The rules for compensation for injury and death in clinical trials have recently been notified. These rules clarify that medical management of all injuries in clinical trials is mandatory and in cases in which injury or death is related to the clinical trial, the subject (or nominee) is entitled to compensation over and above the medical management. They also specify procedures and timelines for reporting serious adverse events. These require simplification. The rules will hopefully make clinical trial safer for subjects and investigators alike. However, they suffer from certain inconsistencies that should be reconsidered. They need to be modified so that they do not damage the industry.
临床试验中伤害与死亡的赔偿规则最近已发布通知。这些规则明确规定,临床试验中所有伤害的医疗处理是强制性的,并且在伤害或死亡与临床试验相关的情况下,受试者(或指定代表)除了获得医疗处理外,还有权获得赔偿。它们还规定了报告严重不良事件的程序和时间框架。这些需要简化。这些规则有望使临床试验对受试者和研究者都更安全。然而,它们存在某些不一致之处,应重新考虑。需要对其进行修改,以免损害该行业。